Parallel Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History
Parallel Advisors, LLC
- $4.34 Billion
- Q4 2024
A detailed history of Parallel Advisors, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Parallel Advisors, LLC holds 16,374 shares of TAK stock, worth $221,703. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,374
Previous 9,397
74.25%
Holding current value
$221,703
Previous $133,000
62.41%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding TAK
# of Institutions
335Shares Held
69.1MCall Options Held
1.99MPut Options Held
171K-
Capital Research Global Investors Los Angeles, CA13.2MShares$178 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$75.8 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$62.7 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$57.1 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.41MShares$46.1 Million0.02% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...